JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.

Call Us 1 - 866 - 986 - 9598
[email protected]

Sign Up

Login
- My Order
- Return Requests
- Track my Order

Home / Proteins & Peptide

Spike RBD (B.1.1.7 Variant), Avi-His-Tag (SARS-CoV-2)

SKU : BHP18201323

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Request More Infos

BPS Bioscience

view supplier details

Order Now

Credit card payments now incur a 3% fee.

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Ask Merchant

Request More Infos

Sample Request

Mfr.No.	100977-2
Description	Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to SARS-CoV-2 Variant B.1.1.7, originally discovered in the United Kingdom, and contains mutation N501Y. It also contains a C-terminal Avi-Tag and a C-terminal His-tag. The recombinant protein is>=90% pure following high affinity Ni-NTA purification. Constructs: Spike RBD (B.1.1.7) (SARS-CoV-2) (319-541-Avi-His)
Immunogen Region	319-541
Tag	C-terminal Avi-His-Tag
Formulation	8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, 20% glycerol
Mutation	Deletions: del6970 HV, del144 YSubstitutions: N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
Species	SARS-CoV-2
Notes	Avoid freeze/thaw cycles.
GenBank	MN908947
Mw(kda)	28 kDa

Synonyms	coronavirus, covid, covid-19, covid19, Sars-cov-2 B117, sars cov 2 Spike RBD, sarscov2, SARS-CoV-2 variant B117, Lineage B.1.1.7, Variant of Conc 20I/501Y.V1, B117 mutation, UK coronavirus, SARS-CoV-2 UK, British variant 100977-1, 100977-2
Uniprot	P0DTD1

Shipping Temperature	-80°C (dry ice)
Purity	>=90%
Storage	At least 6 months at -80°C.

Product Manual	Datasheet

Have you used this product?

Rate it now..!!

Login to Review

SKU	Supplier No.	Size	Your price	Quantity
BHP18201323	100977-2	1 mg	$3135		Add to Cart

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.

© 2024 Biohippo. All rights reserved.